Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term

European Journal of Endocrinology

Volumn 147, Issue 6, 2002, Pages 785-793

  Bersinger, Nick A ^c   Groome, Nigel ^a   Muttukrishna, Shanthi ^b,d  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; FOLLISTATIN; GROWTH FACTOR; HUMAN PLACENTA LACTOGEN; INHIBIN A; LEPTIN; PLACENTA EXTRACT; PLACENTA PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; TISSUE PRESERVATION;

ADULT; DELIVERY, OBSTETRIC; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; REFERENCE VALUES;

EID: 0036924429     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470785     Document Type: Article

References (58)

1. Redman CW. Current topic: Pre-eclampsia and the placenta. Placenta 1991 12 301-308.
2. Redman CW, Sacks GP & Sargent I. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. American Journal of Obstetrics and Gynecology 1999 180 499-506.
3. Muttukrishna S, Knight PG, Groome NP, Redman CW & Ledger WL. Activin A inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997 349 1285-1288.
4. Petraglia F, Aguzzoli L, Gallinelli A, Florio P, Zonca M, Benedetto C et al. Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta 1995 16 447-454.
5. Fraser RF, McAsey ME & Coney P. Inhibin-A and pro-αC are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotrophin. American Journal of Reproductive Immunology 1998 40 37-42.
6. Cuckle H, Sehmi I & Jones R. Maternal serum inhibin A can predict pre-eclampsia. British Journal of Obstetrics and Gynaecology 1998 105 1101-1103.
7. Aquilina J, Barnett A, Thompson O & Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. American Journal of Obstetrics and Gynecology 1999 181 131-136.
8. Silver HM, Lambert GM, Star JA, Hogan J & Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, pre-eclamptic, and non-proteinuric gestationally hypertensive pregnancies. American Journal of Obstetrics and Gynecology 1999 180 1131-1137.
9. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Human Reproduction 2000 15 1640-1645.
10. Petraglia F, Garuti GC, Calza L, Roberts V, Giardino L, Genazzani AR et al. Inhibin subunits in human placenta: localisation and messenger ribonucleic acid levels during pregnancy. American Journal of Obstetrics and Gynecology 1991 165 750-758.
11. Muttukrishna S, George L, Fowler PA, Groome NP & Knight PG. Measurement of serum concentrations of inhibin-A (α-βA dimer) during human pregnancy. Clinical Endocrinology 1995 42 391-397.
12. Muttukrishna S, Fowler PA, George L, Groome NP & Knight PG. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. Journal of Clinical Endocrinology and Metabolism 1996 81 3328-3334.
13. Bischof P. Placental proteins. Contributions in Gynecology and Obstetrics 1984 12 6-92.
14. Hughes G, Bischof P, Wilson G, Smith R & Klopper A. Assay of placental protein to determine fetal risk. British Medical Journal 1980 280 671-673.
15. Toop K & Klopper A. Concentration of pregnancy-associated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia. Placenta 1981 4 (Suppl) 167-174.
16. Westergaard JG & Teisner B. Pregnancy-associated plasma protein A in normal and abnormal late pregnancy. In Pregnancy Proteins, pp 345-354. Eds JG Grudzinskas, B Teisner & M Seppala. Sydney: Academic Press, 1982.
17. Bersinger NA, Smárason AK, Muttukrishna S, Groome NP, Redman CW & Birkhäuser MH. PAPP-A, inhibin A, activin A and sE-selectin are increased in pre-eclampsia serum. The IFPA/8th meeting of the European Placenta Group, Schladming, Austria, 1999. Placenta 1999 20 A13 (Abstract).
18. Chapman MG, O'Shea RT, Jones WR & Hillier R. Pregnancy-specific β1-glycoprotein as a screening test for at-risk pregnancies. American Journal of Obstetrics and Gynecology 1981 141 499-502.
19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432.
20. Leroy P, Dessolin S, Villageois P, Moon BC, Friedman JM, Ailhaud G et al. Expression of ob gene in adipose cells. Journal of Biological Chemistry 1996 271 2365-2368.
21. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 1996 334 292-295.
22. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nature Medicine 1997 3 1029-1033.
23. Highman TJ, Friedman JE, Huston LP, Wong WW & Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. American Journal of Obstetrics and Gynecology 1998 178 1010-1015.
24. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H et al. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. Journal of Clinical Endocrinology and Metabolism 1998 83 3225-3229.
25. Sivan E, Whittaker PG, Sinha D, Homko CJ, Lin M, Reece EA et al. Leptin in human pregnancy: the relationship with gestational hormones. American Journal of Obstetrics and Gynecology 1998 179 1128-1132.
26. Torry DS, Wang HS, Wang TH, Caudle MR & Torry RJ. Pre-eclampsia is associated with reduced serum levels of placenta growth factor. American Journal of Obstetrics and Gynecology 1998 179 1539-1544.
27. Taylor CM, Stevens H, Anthony FW & Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines JEG, JAr and BeWo. Placenta 1997 18 451-458.
28. Ahmed A, Dunk C, Ahman S & Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) and soluble Flt-1 by oxygen - a review. Trophoblast Research (Placenta) 2000 14 S16-S24.
29. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD & Smith SK. Expression of mRNA for vascular endothelial growth factor in human placenta. Journal of Reproduction and Fertility 1993 99 609-615.
30. Roberts JM, Taylor RN & Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome pre-eclampsia. American Journal of Hypertension 1991 4 700-708.
31. Friedman SA, Schiff E, Emeis JJ, Dekker GA & Sibai BM. Biochemical corroboration of endothelial involvement in severe pre-eclampsia. American Journal of Obstetrics and Gynecology 1995 172 202-203.
32. Manuelpillai U, Schneider M, Dole A & Wallace EM. Activin A and activin receptors in gestational tissue from preeclamptic pregnancies. Journal of Endocrinology 2001 171 57-64.
33. Bersinger NA, Zakher A, Huber U, Pescia G & Schneider H. A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Archives of Gynecology and Obstetrics 1995 256 185-192.
34. Bersinger NA, Brandenberger AW & Birkhäuser MH. Endometrial and placental protein markers and ovarian steroids in serum during in vitro fertilisation cycles. Human Reproduction 1995 10 2149-2154.
35. Malek A, Sager R, Lang AB & Schneider H. Protein transport across the in vitro perfused human placenta. American Journal of Reproductive Immunology 1997 38 263-271.
36. Malek A, Willi A, Müller J, Sager R, Hänggi W & Bersinger N. Capacity for hormone production of cultured trophoblast cells obtained from placentae at term and in early pregnancy. Journal of Assisted Reproduction and Genetics 2001 18 299-304.
37. Muttukrishna S, Groome N & Ledger WL. Gonadotropic control of secretion of dimeric inhibins and activin A by human granulosaluteal cells in vitro. Journal of Assisted Reproduction and Genetics 1997 14 566-573.
38. Knight PG, Muttukrishna S & Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. Journal of Endocrinology 1996 148 267-279.
39. Evans LW, Muttukrishna S & Groome NP. Development, validation, and application of an ultra sensitive two-site enzyme immuno assay for human follistatin. Journal of Endocrinology 1998 156 275-282.
40. Malek A, Willi A, Müller J, Sager R, Hänggi W & Bersinger NA. Capacity of hormone production by cultured trophoblast cells obtained from placentae at term and early pregnancy. Journal of Assisted Reproduction and Genetics 2001 18 217-222.
41. Obiekwe BC, Sturdee D, Cockrill BL & Chard T. Human placental lactogen in pre-eclampsia. British Journal of Obstetrics and Gynaecology 1984 91 1077-1080.
42. O'Connor AE, McFarlane JR, Hayward S, Yohkaichiya T, Groome NP & De Kretser DM. Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Human Reproduction 1999 14 827-832.
43. Muttukrishna S, Child TJ, Groome NP & Ledger WL. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Human Reproduction 1997 12 1089-1093.
44. Mohan A, Asselin J, Sargent IL, Groome NP & Muttukrishna S. Effect of cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term placental villous trophoblasts in culture. European Journal of Endocrinology 2001 145 505-511.
45. Wang Y & Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 1998 19 581-586.
46. Yu J, Shao LE, Frigon NL & Schwall R. Induced expression of the new cytokine, activin A, in human monocytes, inhibition by glucocorticoids and retinoic acid. Immunology 1996 88 368-374.
47. Muttukrishna S, Tannetta D, Groome N, Redman C & Sargent I. Secretion of activin A by peripheral blood mononuclear cells (PBMCs) in culture and flowcytometric detection of intracytoplasmic inhibin/activin subunits and activin receptors. The international workshop on inhibins, activins, and follistatins, Melbourne, Australia, October 2000. Molecular and Cellular Endocrinology 2001 180 194 Special Edition.
48. Jackson N, Biddolph SC, Ledger W, Groome NP & Manek S. Inhibin expression in normal and pre-eclamptic placental tissue. International Journal of Gynecological Pathology 2000 19 219-224.
49. Aitken DA, McKinnon D, Crossley JA, Graham GW, Berry E, Spencer K et al. Changes in the maternal serum concentrations of PAPP-A and SP1 in Down's syndrome pregnancies between the first and second trimesters. Journal of Medical Genetics 1994 31 170.
50. Bersinger NA, Marguerat P, Pescia G & Schneider H. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay. importance of first-trimester serum determinations, and stability studies. Reproduction, Fertility and Development 1995 7 1419-1423.
51. Berry E, Aitken DA, Crossley JA, Macri JN & Connor JM. Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters. British Journal of Obstetrics and Gynaecology 1997 104 811-817.
52. Anim-Nyame N, Sooranna SR, Steer PJ & Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Human Reproduction 2000 15 2033-2036.
53. Teppa RJ, Ness RB, Crombleholme WR & Roberts JM. Free leptin is increased in normal pregnancy and further increased in pre-eclampsia. Metabolism 2000 49 1043-1048.
54. Hytinantti T, Koistinen HA, Koivisto VA, Karonen SL, Rutanen EM & Andersson S. Increased leptin concentration in preterm infants of pre-eclamptic mothers. Archives of Disease in Childhood, Fetal and Neonatal Edition 2000 83 F13-F16.
55. Gonzalez RR, Simon C, Caballero-Campo P, Norman R, Chardonnens D, Devoto L et al. Leptin and reproduction. Human Reproduction Update 2000 6 290-300.
56. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J et al. Overexpression of placental leptin in diabetic pregnancy. Diabetes 1998 47 847-850.
57. Chardonnens D, Cameo P, Aubert ML, Pralong FP, Islami D, Campana A et al. Modulation of human cytotrophoblastic leptin secretion by interleukin-1α and 17β-oestradiol and its effect on HCG secretion. Molecular Human Reproduction 1999 5 1077-1082.
58. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Avecedo C et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for 'placental hyperoxia' in intrauterine growth restriction. Laboratory Investigation 1999 79 151-170.